About Penang Enterprises Private Limited
Data last updated:
Penang Enterprises Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 January 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U65990MH1997PTC105511. Its GSTIN is 27AABCS4014L1ZE (Maharashtra). The company holds 7 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹20.64 Lakh. It was formerly known as Samarth Life Sciences Private Limited and Sohini Holdings & Finance Private Limited. It is led by directors Rajiv Gunvantlal Shah and Pranav Gunvantlal Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Samarth House Opposite Movie Star Cinema Ram Mandir Road Goregaon(W) Mumbai – 400 1, 04, Maharashtra, India – 400104.
As per the financials filed for FY 2025, the company reported a revenue of ₹111.42 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹63.21 Cr (net margin 56.7%) and EBITDA of ₹76.04 Cr (EBITDA margin 68.2%). Revenue has declined at a compounded annual rate (CAGR) of 39% over three years and 18% over five years.
Its group structure includes 1 subsidiary.
As per MCA filings, the company has satisfied charges of ₹2.42 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website samarthlife.com.
Company details
Name history
Penang Enterprises has undergone 2 name changes throughout its history. The company was previously known as Samarth Life Sciences Private Limited, and Sohini Holdings & Finance Private Limited. The current legal name is Penang Enterprises Private Limited.
| Company Name | Status |
|---|---|
| Penang Enterprises Private Limited | Current |
| Samarth Life Sciences Private Limited | Previous |
| Sohini Holdings & Finance Private Limited | Previous |
Contact details
Penang Enterprises Private Limited's registered office is in Mumbai, Maharashtra. Its website is samarthlife.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSamarth House Opposite Movie Star Cinema Ram Mandir Road Goregaon(W) Mumbai – 400 1, 04, Maharashtra, India – 400104
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Penang Enterprises Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Penang Enterprises are manufacturing and financial and insurance service. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and other financial activities. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| K | Financial and insurance Service | K8 | Other financial activities |
To see the full business activity and turnover split of Penang Enterprises Private Limited, buy the company report.
Financials of Penang Enterprises Private Limited
FY 2024 filings availablePenang Enterprises Private Limited reported revenue of ₹111.42 Cr (up 21% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 21% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 18%. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹76.04 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹63.21 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 68.2% | ||||
| Net Profit Margin | 56.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Penang Enterprises Private Limited, buy the company report.
Board of directors of Penang Enterprises Private Limited
Penang Enterprises has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajiv Gunvantlal Shah Also directs: Khanuja Estates LLP, Samarth Life Sciences Private Limited, Money Honey Financial Services Private Limited and 4 more | Director | 05 Sep 2014 | 12 Years 2 Months | Current |
| Pranav Gunvantlal Shah Also directs: Money Honey Financial Services Private Limited, Money Honey Consultants Private Limited, Cellcys Labs Private Limited and 1 more | Director | 09 Jan 2023 | 3 Years 9 Months | Current |
Peer comparison
Penang Enterprises Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Seagull Pharmaceuticals Pvt Ltd | ₹113.36 Cr (FY 2025) | 8.0% | Naraina Vihar, Delhi, India | |||
| Stadmed Pvt Ltd | ₹112.88 Cr (FY 2025) | 0.0% | Kolkata, West Bengal, India | |||
| Shree Ganesh Remedies Limited | ₹112.33 Cr (FY 2025) | -13.0% | Anklesvar, Gujarat, India | |||
| Unicure Remedies Private Limited | ₹112.25 Cr (FY 2025) | -13.0% | Vadodara, Gujarat, India | |||
| Apple Formulations Private Limited. | ₹111.56 Cr (FY 2025) | 3.0% | Delhi, India | |||
| Penang Enterprises Private Limitedthis company | ₹111.42 Cr (FY 2025) | ₹63.21 Cr | 56.7% | 21.0% | Mumbai, Maharashtra, India | |
| Horizon Bioceuticals Pvt Ltd | ₹110.37 Cr (FY 2025) | -9.0% | Panipat, Haryana, India | |||
| Inventaa Industries Private Limited | ₹109.72 Cr (FY 2025) | -17.0% | Kanchikacherla, Andhra Pradesh, India |
To see the full peer comparison of Penang Enterprises Private Limited, buy the company report.
Auditor
Penang Enterprises Private Limited is audited by Satish Soni & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Satish Soni & Co. | FY 2023 | 109333W |
Shareholding
The shareholding of Penang Enterprises Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Penang Enterprises Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Nov 2009 | 10184414 | Deputy Director of Industries | ₹2.42 Cr | Satisfied |
To see the full charge records of Penang Enterprises Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Penang Enterprises Private Limited has 1 court case on record: 1 filed by Penang Enterprises. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Writ petition | Filed by the company against Central Board of Direct Taxes and 3 others | Disposed |
To see the full case history of Penang Enterprises Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Penang Enterprises Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Penang Enterprises has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Powertrac Solar Projects Limited | U40106GJ2013PLC076021 |
To see the full group structure of Penang Enterprises Private Limited, buy the company report.
GST
Penang Enterprises has 7 GST registrations: 7 active. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCS4014L1ZE | Maharashtra | Active | 01 Jul 2017 |
| 02AABCS4014L1ZQ | Himachal Pradesh | Active | 01 Jul 2017 |
| 29AABCS4014L1ZA | Karnataka | Active | 01 Jul 2017 |
| 04AABCS4014L1ZM | Chandigarh | Active | 30 Jul 2019 |
To see the full GST registrations and return filing status of Penang Enterprises Private Limited, buy the company report.
Recent activity
Penang Enterprises Private Limited has 7 board changes on record since 2014: 2 appointments and 5 cessations. The latest: Pranav Gunvantlal Shah ceased to be Additional Director on 29 Sep 2023.
Frequently asked questions
Penang Enterprises is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 January 1997 (29+ years old) and is registered under CIN U65990MH1997PTC105511.
Penang Enterprises has 2 current directors:
- Rajiv Gunvantlal Shah - Director
- Pranav Gunvantlal Shah - Director
The latest financial statements of Penang Enterprises on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Penang Enterprises is 27AABCS4014L1ZE, registered in Maharashtra. The company has 7 GST registrations in all, of which 7 are active. Other active GSTINs include 02AABCS4014L1ZQ (Himachal Pradesh), 29AABCS4014L1ZA (Karnataka), 04AABCS4014L1ZM (Chandigarh).
The CIN (Corporate Identification Number) of Penang Enterprises is U65990MH1997PTC105511. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Penang Enterprises has 1 court case on record: 1 filed by the company.
Penang Enterprises was incorporated on 29 January 1997, making it 29+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Penang Enterprises by revenue are Seagull Pharmaceuticals Pvt Ltd, Stadmed Pvt Ltd, Shree Ganesh Remedies Limited, Unicure Remedies Private Limited, Apple Formulations Private Limited. and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Pranav Gunvantlal Shah ceased to be Additional Director on 29 Sep 2023. Pranav Gunvantlal Shah was appointed as Director on 09 Jan 2023. Krishna Murthy Narasimhaprasad ceased to be Additional Director on 28 Dec 2020. Penang Enterprises has 7 board changes on record in total.
Penang Enterprises can be reached through the website samarthlife.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Penang Enterprises is at Samarth House Opposite Movie Star Cinema Ram Mandir Road GoregaonW Mumbai – 400 1, 04, Maharashtra, India – 400104.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
